Adam R.
- Country
- Poland
- Department
- 40396:Oddzial Dermatologii i Dermatologii Onkologicznej
Research Overview
- A Phase 1 Randomized, Double‑Blind, Placebo‑Controlled Study of BBT001 in Healthy Volunteers and Adults with Atopic Dermatitis
- Efficacy and Safety of Zasocitinib in Patients with Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 442 of 762 partner sites.
Specializations
Inflammatory Skin Disease
Clinical research is centered on atopic dermatitis, plaque psoriasis, hidradenitis suppurativa, and related chronic inflammatory dermatoses, with attention to treatment response, symptom control, and long-term disease management.
- Atopic dermatitis
- Plaque psoriasis
- Hidradenitis suppurativa
- Prurigo nodularis
- Acne vulgaris
Work in this area also includes palmoplantar pustulosis and actinic keratosis, reflecting a strong dermatologic focus on persistent inflammatory and keratinization disorders.
Autoimmune and Lupus-Related Dermatology
Research activity includes cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, chronic cutaneous lupus erythematosus, and primary discoid lupus erythematosus, with interest in skin-limited autoimmune disease and refractory cutaneous manifestations.
- Cutaneous lupus erythematosus
- Subacute cutaneous lupus erythematosus
- Chronic cutaneous lupus erythematosus
- Primary discoid lupus erythematosus
- Bullous pemphigoid
Additional involvement extends to anifrolumab- and BIIB059-focused studies in autoimmune skin disease, supporting therapeutic development in difficult-to-treat cutaneous autoimmune disorders.
Pruritic and Urticarial Disorders
Another key area is the management of chronic spontaneous urticaria, chronic inducible urticaria, and itch-driven conditions such as prurigo nodularis, where symptom burden and quality of life are central therapeutic concerns.
- Chronic spontaneous urticaria
- Chronic inducible urticaria
- Cold-induced urticaria
- Symptomatic dermographism
- Prurigo nodularis
Research in this domain also includes barzolvolimab, remibrutinib, and nemolizumab programs, emphasizing targeted approaches for persistent pruritus and urticarial activity.
Pediatric and Adolescent Dermatology
Clinical trial involvement extends to pediatric atopic dermatitis, pediatric plaque psoriasis, and alopecia areata in younger populations, showing a therapeutic focus on age-specific dermatologic care.
- Pediatric atopic dermatitis
- Pediatric plaque psoriasis
- Alopecia areata
- Vitiligo
- Non-segmental vitiligo
This area also includes studies in adolescents and children with chronic inflammatory and pigmentary disorders, broadening access to newer dermatologic therapies across developmental stages.
Oncology and Other Therapeutic Areas
Beyond dermatology, research involvement includes non-small cell lung cancer, pleural mesothelioma, colorectal cancer, and myelodysplastic syndrome, reflecting engagement with oncologic and hematologic treatment development.
- Non-small cell lung cancer
- Pleural mesothelioma
- Colorectal cancer
- Myelodysplastic syndrome
- Sudden sensorineural hearing loss
Additional interest is seen in electronic cigarette cessation and nephrotic syndrome, indicating participation in selected non-dermatologic therapeutic domains.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.